Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy

Journal of Dermatology

Volumn 39, Issue 8, 2012, Pages 711-714

  Yamaguchi, Sayaka ^a   Yamamoto, Yuichi ^a   Hosokawa, Atsushi ^a   Hagiwara, Keisuke ^a,b   Uezato, Hiroshi ^a   Takahashi, Kenzo ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Chuo Dermatological Office   (Japan)

Author keywords

deep venous thrombosis; erythema nodosum leprosum; leprosy; pulmonary embolism; thalidomide

Indexed keywords

CYCLOSPORIN A; D DIMER; DAPSONE; HEPARIN; OFLOXACIN; PREDNISOLONE; RIFAMPICIN; THALIDOMIDE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARM PAIN; ARTICLE; BORDERLINE LEPROSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; ERYTHEMA; ERYTHEMA NODOSUM LEPROSUM; FEVER; HAND PARESTHESIA; HISTOPATHOLOGY; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAPANESE; LEPROMATOUS LEPROSY; LUNG EMBOLISM; MALE; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PROTHROMBIN TIME; SENSORY DYSFUNCTION; SKIN BIOPSY; SKIN DEFECT; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; CYCLOSPORINE; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; PULMONARY EMBOLISM; THALIDOMIDE; TREATMENT OUTCOME; VENOUS THROMBOSIS; WARFARIN;

EID: 84864398434     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01484.x     Document Type: Article

References (22)

1. Wu JJ, Huang DB, Pang KR, Hus S, Tyring SK,. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol 2005; 153: 254-273. (Pubitemid 41228421)
2. Zonder JA,. Thrombotic complications of myeloma therapy. Hematology Am Soc Hematol Educ Program 2006: 348-355.
3. Cavenagh JD, Oakervee H,. Thalidomide in multiple myeloma: current status and future prospects. Br J Haematol 2003; 120: 18-26.
4. Kahawita IP, Lockwood DN,. Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 2008; 102: 329-337.
5. Teo SK, Resztak KE, Scheffler MA, et al. Thalidomide in the treatment of leprosy. Microbes Infect 2002; 4: 1193-1202. (Pubitemid 35279527)
6. Manandhar R, LeMaster JW, Roche PW,. Risk factors for erythema nodosum leprosum. Int J Lepr Other Mycobact Dis 1999; 67: 270-278. (Pubitemid 29536457)
7. Pocaterra L, Jain S, Reddy R, et al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 2006; 74: 868-879. (Pubitemid 46774411)
8. Moschella SL,. An update on the diagnosis and treatment of leprosy. J Am Acad Dermatol 2004; 51: 417-426. (Pubitemid 39178670)
9. Scollard DM, Adams LB, Gillis TP, Krahenduhl JL, Truman RW, Williams DL,. The continuing challenges of leprosy. Clin Microbiol Rev 2006; 19: 338-381.
10. Sheskin J,. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965; 6: 303-306.
11. Sheskin J, Convit J,. Results of a double blind study of the influence of thalidomide on the lepra reaction. Int J Lepr 1969; 37: 135-146.
12. Kaur I, Dogra S, Narang T, De D,. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study. Australas J Dermatol 2009; 50: 181-185.
13. Iyer CG, Languillon J, Ramanujam K, et al. WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull World Health Organ 1971; 45: 719-732.
14. Deng L, Ding W, Granstein RD,. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells. J Invest Dermatol 2003; 121: 1060-1065. (Pubitemid 37430974)
15. Ramzi N, Accaoui EI, Shamseddeen WA, Taher A,. Thalidomide and thrombosis. A meta-analysis. Thromb Haemost 2007; 97: 1031-1036.
16. Corso A, Lornezi A, Terulla V, et al. Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone. Ann Hematol 2004; 83: 588-591. (Pubitemid 39209183)
17. Baz R, Li L, Kottke-Marchant K, et al. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma. Mayo Clin Proc 2005; 80: 1568-1574. (Pubitemid 41747058)
18. Rajkumar SV,. Thalidomide therapy and deep venous thrombosis in multiple myeloma. Mayo Clin Proc 2005; 80: 1549-1551. (Pubitemid 41747055)
19. Sharma NL, Sharma V, Shanker V, Mahajan VK, Sarin S,. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum. Int J Lepr Other Mycobact Dis 2004; 72: 483-485. (Pubitemid 40179985)
20. Vetrichevvel TP, Pise GA, Thappa DM,. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide. Lepr Rev 2008; 79: 193-195.
21. Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP,. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. J Drugs Dermatol 2009; 8: 765-769.
22. Medeiros S, Fernandes C, Martins N, et al. Hansen's disease in an HIV patient complicated by deep vein thrombosis: a rare complication of thalidomide therapy. Eur J Dermatol 2009; 19: 272-273.